Lupin Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Lupin Announces the Approval of Dapagliflozin Tablets in the United States".
Lupin Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Lupin Announces the Approval of Dapagliflozin Tablets in the United States".